We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
1601
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-1,040
Closed -$49K
IMGN
1602
DELISTED
Immunogen Inc
IMGN
– –
-4,630
Closed -$26K
ORTX
1603
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-169
Closed -$3K
AMTI
1604
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-880
Closed -$22K
ICPT
1605
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-765
Closed -$11K
RVLP
1606
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-1,440
Closed -$4K
RETA
1607
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-720
Closed -$72K
PRTK
1608
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-1,110
Closed -$5K
SURF
1609
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-1,040
Closed -$7K
HARP
1610
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-75
Closed -$5K
KDNY
1611
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-1,025
Closed -$13K
SPPI
1612
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-3,755
Closed -$8K
ISEE
1613
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-2,375
Closed -$38K
TCRR
1614
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-875
Closed -$7K
JNCE
1615
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-1,170
Closed -$8K
BBBY
1616
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-23,713
Closed -$409K
PRVB
1617
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-1,450
Closed -$9K
QTT
1618
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
– –
-20,789
Closed -$205K
CNCE
1619
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-740
Closed -$2K
RUBY
1620
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-2,060
Closed -$36K
ATNX
1621
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-125
Closed -$7K
TCDA
1622
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-1,155
Closed -$5K
CLVS
1623
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-2,705
Closed -$12K
AKUS
1624
DELISTED
Akouos Inc
AKUS
– –
-785
Closed -$9K
AERI
1625
DELISTED
Aerie Pharmaceuticals
AERI
– –
-1,080
Closed -$12K
63 64
65
66 67

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.